Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Arrhythmia Research Technology, Inc Announces Results Second Quarter 2003.


Business Editors/Health/Medical Writers

FITCHBURG, Mass.--(BUSINESS WIRE)--Aug. 5, 2003

Arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of  Research Technology, Inc. (the "Company")(AMEX AMEX

See: American Stock Exchange
: HRT HRT
abbr.
hormone replacement therapy


Hormone replacement therapy (HRT)
Also called estrogen replacement therapy, this controversial treatment is used to relieve the discomforts of menopause.
) and it's wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 Micron Products, Inc. (Micron) reported total revenue of $1,940,000 and net income of $285,000 for the second quarter of 2003 compared to total revenue of $1,832,000 and net income of $101,000 for the second quarter 2002. The net income for the six months ended 2003 is 129% higher than the same period in 2002.

                            Three Months Ending    Six Months Ending
                                 June 30,              June 30,
                             2003       2002       2003       2002
Revenues                   1,939,635  1,832,237  3,815,203  3,747,334
Net Income                   284,981    101,440    564,336    246,461
Net Income per share
 (basic and diluted)            0.11       0.03       0.21       0.08
Weighted Average Shares
 Outstanding (basic)       2,600,213  2,907,124  2,643,785  2,912,464


The management stated that in addition to being on track to surpass fiscal 2002 results, the Company continues to explore all opportunities for expansion and growth.

The increase in net income is attributable to both the growing diversity of product mix and a larger unit volume of sales. The unit volume of sales increased greater than ten percent in the first six months of 2003 versus the same period in 2002. In our competitive market, this substantial increase in unit volume does not directly result in an equal increase in sales dollars.

Micron Products, Inc. produces silver plated sensors and distributes metal snaps for manufacturers of disposable ECG ECG electrocardiogram.

ECG
abbr.
1. electrocardiogram

2. electrocardiograph


ECG
Also called an electrocardiogram, it records the electrical activity of the heart.
 electrodes. The Company's products include proprietary signal-averaging electrocardiographic electrocardiographic

emanating from or pertaining to electrocardiography.


electrocardiographic monitoring
maintenance of a more or less continuous surveillance of a patient's cardiac status by means of electrocardiography.
 (SAECG SAECG Signal-Averaged Electrocardiogram ) software used in the detection and treatment of potentially lethal heart arrhythmias.

Forward-looking statements made herein are based on current expectations of the Company that involve a number of risks and uncertainties and should not be considered as guarantees of future performance. The factors that could cause actual results to differ materially include: interruptions or cancellation of existing contracts, impact of competitive products and pricing, product demand and market acceptance, risks, the presence of competitors with greater financial resources than the Company, product development and commercialization risks and an inability to arrange additional debt or equity financing Equity Financing

The act of raising money for company activities by selling common or preferred stock to individual or institutional investors. In return for the money paid, shareholders receive ownership interests in the corporation.
. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2003.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 5, 2003
Words:406
Previous Article:Mitcham Sells Front-End Services Operating Assets.
Next Article:John Hancock Patriot Premium Dividend Fund I Declares Monthly Dividend.
Topics:



Related Articles
Heart drug trial cut short.
Dogs shed light on human arrhythmias.
Arrhythmias/rhythm disorders.
NORTRAN DRUG EFFECTIVE IN ATRIAL ARRHYTHMIA MODEL.
NOTES : OLAJUWON BACK IN HOSPITAL.
"Heart rhythm" & "J. of the American College of Radiology".
Follow up ...
Calling death's bluff: implantable defibrillators can save thousands of lives--but which ones?

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles